FRANCA, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 4.626
EU - Europa 2.934
AS - Asia 2.379
SA - Sud America 328
AF - Africa 91
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.378
Nazione #
US - Stati Uniti d'America 4.541
SG - Singapore 870
PL - Polonia 668
IT - Italia 587
CN - Cina 529
SE - Svezia 268
DE - Germania 266
VN - Vietnam 255
BR - Brasile 246
HK - Hong Kong 239
UA - Ucraina 190
FI - Finlandia 188
FR - Francia 168
GB - Regno Unito 145
RU - Federazione Russa 101
KR - Corea 95
IN - India 78
TR - Turchia 77
NL - Olanda 71
IE - Irlanda 64
JP - Giappone 53
BG - Bulgaria 47
MX - Messico 36
ES - Italia 33
AR - Argentina 30
CA - Canada 29
BD - Bangladesh 26
BE - Belgio 24
MA - Marocco 21
PK - Pakistan 19
CH - Svizzera 18
IQ - Iraq 17
AT - Austria 16
AU - Australia 16
EG - Egitto 14
PT - Portogallo 14
SN - Senegal 14
TH - Thailandia 14
ID - Indonesia 13
SA - Arabia Saudita 13
TN - Tunisia 13
CL - Cile 11
SI - Slovenia 11
JO - Giordania 10
UZ - Uzbekistan 10
EC - Ecuador 9
PE - Perù 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
IR - Iran 7
PY - Paraguay 7
CO - Colombia 6
GR - Grecia 6
KE - Kenya 6
MY - Malesia 6
PH - Filippine 6
TW - Taiwan 6
VE - Venezuela 6
NO - Norvegia 5
RO - Romania 5
AZ - Azerbaigian 4
CR - Costa Rica 4
PR - Porto Rico 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
IL - Israele 3
LT - Lituania 3
MD - Moldavia 3
PS - Palestinian Territory 3
UY - Uruguay 3
AL - Albania 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
Totale 10.364
Città #
Warsaw 609
Singapore 515
Ashburn 501
Woodbridge 397
Fairfield 378
Ann Arbor 370
Chandler 331
San Jose 278
Hong Kong 233
Trieste 232
Houston 228
Wilmington 196
Jacksonville 172
Seattle 170
Cambridge 139
Munich 134
Beijing 117
Helsinki 110
Ho Chi Minh City 87
Princeton 87
Seoul 85
Boardman 82
Hefei 78
Los Angeles 67
Hanoi 64
Chicago 59
Dublin 51
Lauterbourg 49
Izmir 47
Sofia 47
London 46
Moscow 45
Zgierz 45
Santa Clara 44
Columbus 43
Frankfurt am Main 39
The Dalles 38
Dallas 36
São Paulo 36
Council Bluffs 35
New York 33
Dearborn 31
Buffalo 28
Düsseldorf 28
Tokyo 27
Milan 25
Bremen 23
Brussels 21
Rome 21
Casablanca 17
Falls Church 16
Fano 16
Shanghai 16
Turku 16
Phoenix 15
Dakar 14
Orem 14
Atlanta 13
Guangzhou 13
San Diego 13
Shannon 13
Chennai 12
Des Moines 12
Mumbai 12
Redondo Beach 12
Bern 11
Genoa 11
Istanbul 11
Manchester 10
Nuremberg 10
Redwood City 10
Stockholm 10
Tashkent 10
Washington 10
Amsterdam 9
Baghdad 9
Brooklyn 9
Curitiba 9
Denver 9
Montreal 9
Nanjing 9
Sydney 9
Bengaluru 8
Chihuahua City 8
Dong Ket 8
Fremont 8
Hangzhou 8
Ljubljana 8
Madrid 8
Venice 8
Vienna 8
Amman 7
Bangkok 7
Brasília 7
Cairo 7
Campo Grande 7
Haiphong 7
Jinan 7
Kocaeli 7
Kunming 7
Totale 7.081
Nome #
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 497
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 463
Pharmacogenetics of thiopurines 447
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 424
Pharmacogenetics of treatments for inflammatory bowel disease 353
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 318
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 279
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 270
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 264
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 261
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 254
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 252
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 248
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 247
Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. 240
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 228
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol 227
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 225
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 221
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 216
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. 207
Human Immunodeficiency Virus (HIV-1) Auxiliary Protein Vif and Cellular APOBEC Deaminases: Their Roles Unveiled? 205
Glutathione S-Transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. 204
Personalized therapies in pediatric inflammatory and autoimmune diseases. 199
TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype 194
Expression of kidney and liver bilitranslocase in response to acute biliary obstruction. 193
Heterodimeric amino acid transporter glycoprotein domains determining functional subunit association 192
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 189
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 188
The ectopic F(O)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1. 184
Human DEAD-box ATPase DDX3 shows a relaxed nucleoside substrate specificity 175
DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. 174
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 171
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 164
Identification and Functional Characterization of Bilitranslocase in Sea-Bass (Dicentrarchus labrax) Hepatopancreas 163
Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia 161
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 156
Processes for incorporation of pharmacogenetic tests and interpretations in medical records for clinical practice. 152
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism 149
ITPA genetic polymorphism is possibly associated with survival rate in Korean children with acute lymphoblastic leukemia. 147
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 146
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 142
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 138
Biomarkers for gastrointestinal adverse events related to thiopurine therapy 133
SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation 127
Impact of mercaptopurine metabolites on disease outcome in the AIEOP-BFM ALL 2009 protocol for acute lymphoblastic leukemia 123
Pharmacogenetics of glucocorticoid response 108
The Role of Candidate Polymorphisms in Drug Transporter Genes on High-Dose Methotrexate in the Consolidation Phase of the AIEOP-BFM ALL 2009 Protocol 95
Pharmacological evaluation of drug therapies in Aicardi-Goutières syndrome: insights from patient-derived neural stem cells 88
Totale 10.601
Categoria #
all - tutte 28.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 0 0 0 0 89 38 61
2021/2022577 32 38 28 31 24 51 46 28 68 61 40 130
2022/20231.008 96 155 62 145 96 160 8 94 108 30 46 8
2023/2024685 34 54 30 46 65 48 114 116 7 28 79 64
2024/20251.767 51 91 114 168 159 174 157 137 231 223 139 123
2025/20262.916 352 132 214 244 299 265 487 102 430 391 0 0
Totale 10.601